Kristen K. Buck
2023
In 2023, Kristen K. Buck earned a total compensation of $969.8K as Executive Vice President of Research Development and Chief Medical Officer at Caladrius Biosciences, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $293,548 |
|---|---|
| Option Awards | $18,576 |
| Salary | $574,443 |
| Stock Awards | $75,000 |
| Other | $8,250 |
| Total | $969,817 |
Buck received $574.4K in salary, accounting for 59% of the total pay in 2023.
Buck also received $293.5K in bonus, $18.6K in option awards, $75K in stock awards and $8.3K in other compensation.
Rankings
In 2023, Kristen K. Buck's compensation ranked 1,252nd out of 3,006 executives tracked by ExecPay. In other words, Buck earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,252 out of 3,006 | 58th |
Division Manufacturing | 743 out of 1,650 | 55th |
Major group Chemicals And Allied Products | 499 out of 918 | 46th |
Industry group Drugs | 487 out of 881 | 45th |
Industry Pharmaceutical Preparations | 336 out of 637 | 47th |
Source: SEC filing on April 29, 2024.
Buck's colleagues
We found two more compensation records of executives who worked with Kristen K. Buck at Caladrius Biosciences in 2023.